Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment - ScienceDirect
Response to anti-CTLA-4 immunotherapy Day 16 post-YUMMER1.7... | Download Scientific Diagram
Potential function of CTLA‑4 in the tumourigenic capacity of melanoma stem cells
Frontiers | Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response - ScienceDirect
Schematic representation of CTLA-4 and anti-CTLA-4 mechanisms of action... | Download Scientific Diagram
Mechanisms of action of CTLA-4 and CTLA-4 inhibitors (ipilimumab) A)... | Download Scientific Diagram
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours | Nature
Mechanism of CTLA 4 and PD-1/PD-L1 inhibition. The activation of T... | Download Scientific Diagram
Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity | PLOS ONE
Frontiers | CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy
Anti-mCTLA4 Monoclonal Antibody | Murine Recombinant 9D9
800 Dual targeting of CTLA-4 and CD47 on Treg cells rejuvenates immunity against solid tumors | Journal for ImmunoTherapy of Cancer
Reduce, Reuse, Recycle to improve anti-CTLA-4 therapy
Cancers | Free Full-Text | CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
Definition of CTLA-4 - NCI Dictionary of Cancer Terms - NCI
Immunothérapie dans les cancers digestifs – FMC-HGE
Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice | Cell Research
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners | SpringerLink
John Libbey Eurotext - Journal de Pharmacie Clinique - PK/PD relationships of therapeutic monoclonal antibodies used in oncology
Molecules | Free Full-Text | Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology | HTML
Rotavirus vaccine and anti-CTLA-4: a dynamic duo
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody | PNAS
CTLA-4 Antibody (F-8) | SCBT - Santa Cruz Biotechnology
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action - Willsmore - 2021 - European Journal of Immunology - Wiley Online Library
T-cell activation by anti-CTLA-4 antibodies. Notes: (A) Tumor antigens... | Download Scientific Diagram
